SanBio Company Limited (TYO:4592)
Japan
· Delayed Price · Currency is JPY 2,161.00
-220.00 (-9.24%)
Jun 27, 2025, 3:30 PM JST
SanBio Company Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 3,586 | 2,921 | 4,454 | 6,732 | 4,557 | 12,480 | Upgrade
|
| Cash & Short-Term Investments | 3,586 | 2,921 | 4,454 | 6,732 | 4,557 | 12,480 | Upgrade
|
| Cash Growth | -9.37% | -34.42% | -33.84% | 47.73% | -63.49% | -8.54% | Upgrade
|
| Inventory | - | - | - | - | 467 | 444 | Upgrade
|
| Other Current Assets | 410.76 | 414 | 483 | 235 | 327 | 207 | Upgrade
|
| Total Current Assets | 3,997 | 3,335 | 4,937 | 6,967 | 5,351 | 13,131 | Upgrade
|
| Property, Plant & Equipment | 41.21 | 40 | 44 | 47 | 58 | 141 | Upgrade
|
| Long-Term Investments | 124.85 | 27 | 21 | 28 | 34 | 16 | Upgrade
|
| Other Intangible Assets | 43.89 | 43 | 43 | 1 | 66 | 53 | Upgrade
|
| Other Long-Term Assets | 0 | 2 | 2 | 2 | 1 | 2 | Upgrade
|
| Total Assets | 4,207 | 3,447 | 5,047 | 7,045 | 5,510 | 13,343 | Upgrade
|
| Accounts Payable | 181.31 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Accrued Expenses | 101.83 | 313 | 494 | 374 | 472 | 561 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 500 | Upgrade
|
| Current Portion of Long-Term Debt | 268 | 268 | 268 | 268 | 512 | 975 | Upgrade
|
| Current Income Taxes Payable | 0.3 | 139 | 133 | 331 | 462 | 424 | Upgrade
|
| Other Current Liabilities | 9.02 | 11 | 9 | 116 | 16 | 7 | Upgrade
|
| Total Current Liabilities | 560.46 | 732 | 905 | 1,090 | 1,463 | 2,468 | Upgrade
|
| Long-Term Debt | 1,147 | 129 | 397 | 665 | 2,012 | 2,525 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 604.25 | 823 | 952 | 860 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | 1 | 1 | 2 | - | 1 | Upgrade
|
| Total Liabilities | 2,312 | 1,685 | 2,255 | 2,617 | 3,475 | 4,994 | Upgrade
|
| Common Stock | 2,996 | 2,496 | 3,316 | 6,407 | 4,075 | 5,561 | Upgrade
|
| Additional Paid-In Capital | 6,708 | 6,207 | 7,027 | 10,118 | 7,786 | 9,272 | Upgrade
|
| Retained Earnings | -2,230 | -698 | -1,950 | -8,177 | -9,057 | -7,356 | Upgrade
|
| Treasury Stock | -1.16 | -1 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | -5,577 | -6,242 | -5,601 | -3,920 | -769 | 872 | Upgrade
|
| Shareholders' Equity | 1,895 | 1,762 | 2,792 | 4,428 | 2,035 | 8,349 | Upgrade
|
| Total Liabilities & Equity | 4,207 | 3,447 | 5,047 | 7,045 | 5,510 | 13,343 | Upgrade
|
| Total Debt | 1,415 | 397 | 665 | 933 | 2,524 | 4,000 | Upgrade
|
| Net Cash (Debt) | 2,171 | 2,524 | 3,789 | 5,799 | 2,033 | 8,480 | Upgrade
|
| Net Cash Growth | -35.37% | -33.39% | -34.66% | 185.24% | -76.03% | -12.09% | Upgrade
|
| Net Cash Per Share | 31.16 | 36.65 | 58.00 | 100.12 | 39.26 | 163.75 | Upgrade
|
| Filing Date Shares Outstanding | 72.01 | 72.01 | 68.63 | 64.85 | 53.25 | 51.79 | Upgrade
|
| Total Common Shares Outstanding | 72.01 | 70.93 | 67.93 | 64.08 | 51.79 | 51.79 | Upgrade
|
| Working Capital | 3,437 | 2,603 | 4,032 | 5,877 | 3,888 | 10,663 | Upgrade
|
| Book Value Per Share | 26.31 | 24.84 | 41.10 | 69.11 | 39.29 | 161.22 | Upgrade
|
| Tangible Book Value | 1,851 | 1,719 | 2,749 | 4,427 | 1,969 | 8,296 | Upgrade
|
| Tangible Book Value Per Share | 25.70 | 24.24 | 40.47 | 69.09 | 38.02 | 160.20 | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.